Pancreatic tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients admitted between January 2020 and September 2024, aged >=18 years, and pathologically confirmed as pancreatic ductal adenocarcinoma or pancreatic cystic diseases (including pancreatic serous cystadenoma, pancreatic solid pseudopapillary tumor, pancreatic mucinous cystadenoma); 2. with available pre-treatment hepatobiliary and pancreatic ultrasound images;
Exclusion criteria
Exclusion criteria: 1. Age < 18 years, or patients with an unclear pathological diagnosis; 2. absence of pre-treatment hepatobiliary and pancreatic ultrasound images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall correct classification rate for distinguishing different types of pancreatic tumors;Agreement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Precision;Recall;F1 score; | — |
Countries
China
Contacts
The First Affiliated Hospital of University of Science and Technology of China